Can Adalimumab Reduce the Extent of Hidradenitis Suppurativa Surgery?

JAMA Surg. 2022 Jun 1;157(6):552-553. doi: 10.1001/jamasurg.2022.0083.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adalimumab / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / surgery
  • Humans
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents
  • Adalimumab